Efficacy and Safety of Finlândia Hair Lotion Association on Androgenetic Alopecia
National, Multicentre, Randomized, Double-blind, Double-dummy Phase III Clinical Trial to Evaluate the Efficacy and Safety of Finlândia Hair Lotion Association in the Treatment of Androgenetic Alopecia.
In the register
The register attaches this trial to Finasteride (Propecia) (Organon), currently at “Approved” in the register. The programme's phase is checked by hand; the trial's is declared by its sponsor.
What the registry records
- Status
- Recruiting
- Declared phase
- Phase 3
- Sponsor
- EMS
- Participants (registry)
- 190
- Start
- February 2023
- Primary completion
- May 2026
- Study completion
- September 2027 (planned)
- Last registry update
- December 2025
- Countries
- Brazil
Conditions studied: Androgenetic Alopecia
Interventions: Finlândia Association + finasteride placebo, Minoxidil + finasteride
Other trials of Finasteride (Propecia)
Effectiveness and Safety of Topical Finasteride and Minoxidil Combination Compared to Topical Minoxidil for The Treatment of Male Androgenetic Alopecia
Association of Polymorphisms in the Androgen Receptor Gene and Finasteride Response in Women With Androgenetic Alopecia
Effects of Finasteride on Serum Prostate-Specific Antigen (0906-111)
Listing a trial is not a recommendation to join one. Eligibility, risks and costs vary enormously — discuss any trial with your own doctor first. A registration proves a sponsor declared a study, not that it is progressing or will succeed. We're not doctors.